DarioHealth reported a quarterly loss of $0.81 per share, wider than the Zacks Consensus Estimate for a $0.71 loss. The result also remains unprofitable, though it improved from a $1.20 loss per share a year ago. The miss versus consensus is modest but likely negative for sentiment around the stock.
DarioHealth reported a quarterly loss of $0.81 per share, wider than the Zacks Consensus Estimate for a $0.71 loss. The result also remains unprofitable, though it improved from a $1.20 loss per share a year ago. The miss versus consensus is modest but likely negative for sentiment around the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately negative
Sentiment Score
-0.28
Ticker Sentiment
